Avantor Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Avantor Inc in the third quarter 2026?
Avantor Inc achieved a return on average equity (ROE) of 5.96 % in its third quarter 2026, which is below Avantor Inc 's average return on equity, which stands at 7.3%.

ROE has advanced compared to -10.34% in the second quarter 2026, due to net income growth.

Within the Laboratory Analytical Instruments industry 4 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from 2045 to 2671.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Equity Change	4.77 %	-10.43 %	-8.35 %	-6.58 %	-
Y / Y Net Income Change	-	-41.11 %	-32.87 %	-89.53 %	-
Net Income (TTM) in Millions	337	-578	-551	-530	-82
Return On Equity (TTM)	5.96 %	-10.34 %	-9.59 %	-9.02 %	-1.38 %
AVTR's Total Ranking	# 2671	# 2045	# 643	#	#
Equity (TTM) in Millions	5,836	5,630	5,589	5,565	5,570
Seq. Equity Change	3.65 %	0.74 %	0.43 %	-0.09 %	-11.39 %
Seq. Net Income Change	433.86 %	-12.01 %	-17.37 %	-	-

Back to AVTR Management Effectiveness >> AVTR's 5 Years Annual ROE >> Compare AVTR ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 5
Sector	# 162
Overall	# 2671

Return On Equity Statistics
High	Average	Low
16.87 %	7.3 %	-10.34 %
(Sep 30 2021)		(Jun 30 2026)

AVTR Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2020
Total Equity in Millions	5,565	5,957	5,253	4,855	4,197
Y / Y Equity Change	-6.58 %	13.4 %	8.18 %	15.69 %	70.46 %
Net Income in Millions	-530	712	321	687	573
Y / Y Net Income Change	-	121.58 %	-53.23 %	19.89 %	1414.81 %
Return On Equity	-9.53 %	11.94 %	6.11 %	14.14 %	13.64 %

Back to AVTR Management Effectiveness >> AVTR's 5 Years Annual ROE >> Compare AVTR ROE to its Competitors

More Return On Equity Ratios
Laboratory Analytical Instruments Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
AVTR's' Return on Equity at Yahoo Finance
AVTR's Roe Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for AVTR's Competitors
Subscribers only: Roe for Avantor Inc 's Suppliers
Subscribers only: Return On Equity for AVTR's Customers

Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector	ROE
Lemaitre Vascular Inc	15.81 %
Stryker Corp	15.61 %
Quest Diagnostics Inc	15.22 %
Regeneron Pharmaceuticals Inc	15.07 %
Bio rad Laboratories Inc	14.07 %
Boston Scientific Corporation	13.75 %
Inspire Medical Systems inc	12.49 %
Haemonetics Corporation	12.07 %
Labcorp Holdings Inc	11.55 %
Henry Schein Inc	11.29 %
Medinotec Inc	10.97 %
Tactile Systems Technology Inc	10.73 %
Penumbra Inc	10.44 %
Teleflex Incorporated	9.67 %
Merit Medical Systems Inc	9.65 %
U S Physical Therapy Inc	9.48 %
Abbott Laboratories	9.00 %
Pacific Health Care Organization Inc	8.10 %
Incyte Corporation	7.08 %
Conmed Corporation	7.07 %
Teva Pharmaceutical Industries Limited	6.37 %
Integer Holdings Corporation	6.02 %
Avantor Inc	5.96 %
Ligand Pharmaceuticals Incorporated	5.22 %
Lifestance Health Group Inc	4.82 %
Jazz Pharmaceuticals Plc	4.62 %
Pfizer Inc	4.62 %
Innovage Holding Corp	4.52 %
Icu Medical Inc	2.81 %
Biogen Inc	1.86 %

Date modified: 2026-10-29T09:56:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.